In my view, Kenvue presented acceptably solid results for 2024. Check out my options-based strategy for KVUE stock that ...

Johnson & Johnson’s consumer health spinout Kenvue is quickly amassing a track record of being a target for activist ...

Kenvue Inc. (KVUE) shares will likely draw investor attention Monday morning following a Bloomberg report over the weekend that TOMS Capital had built up an undisclosed stake in the consumer health ...

Syensqo marks 10 years of championing sustainable sourcing for the beauty industry with the Sustainable Guar Initiative, ...

“With rich knowledge of human needs and deep consumer insights, Kenvue will deliver meaningful, personal health solutions,” a Johnson & Johnson press release stated. CEO designate of ...

The AI Edition’ explores four key areas to provide a comprehensive overview of AI's evolving role in the advertising ...

These industry leaders are dedicated to keeping residents healthy, while the new facilities rising around New Jersey will undoubtedly improve research and access to care, keeping the state at the ...

CEO Warren Buffett has one of the most impressive ... However, at the time of the spinoff, J&J still owned roughly 90% of Kenvue stock, so it remains heavily invested in its major consumer ...

Kenvue settles proxy fight with activist Starboard ... lifting its shares to a four-month high as its CEO somewhat allayed investor impatience with his turnaround efforts. Bayer faces investors ...

Kenvue, which was spun out of Johnson & Johnson in 2023, had a market value of about $45 billion at close of trading in New York on Friday. A spokesperson for TOMS declined to comment.